40 related articles for article (PubMed ID: 19293259)
1. Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas.
Dellas A; Jundt G; Sartorius G; Schneider M; Moch H
Clin Cancer Res; 2009 Apr; 15(7):2456-62. PubMed ID: 19293259
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C alpha-dependent signaling mediates endometrial cancer cell growth and tumorigenesis.
Haughian JM; Reno EM; Thorne AM; Bradford AP
Int J Cancer; 2009 Dec; 125(11):2556-64. PubMed ID: 19672862
[TBL] [Abstract][Full Text] [Related]
3. Correlation between NDRG1 and PTEN expression in endometrial carcinoma.
Chen J; Li S; Yang Z; Lu G; Hu H
Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423
[TBL] [Abstract][Full Text] [Related]
4. Loss of nuclear p27(kip1) and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma.
Sgambato A; Camerini A; Genovese G; De Luca F; Viacava P; Migaldi M; Boninsegna A; Cecchi M; Sepich CA; Rossi G; Arena V; Cittadini A; Amoroso D
Cancer Sci; 2010 Sep; 101(9):2080-6. PubMed ID: 20626751
[TBL] [Abstract][Full Text] [Related]
5. p27
Zhu M; Sun S; Huang L; Gao L; Chen M; Cai J; Wang Z; Peng M
Histol Histopathol; 2024 May; ():18761. PubMed ID: 38818655
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients.
Mauland KK; Ju Z; Tangen IL; Berg A; Kalland KH; Øyan AM; Bjørge L; Westin SN; Krakstad C; Trovik J; Mills GB; Hoivik EA; Johanna Werner HM
Oncotarget; 2017 Dec; 8(63):106989-107001. PubMed ID: 29291005
[TBL] [Abstract][Full Text] [Related]
7. Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and Prognosis.
Joehlin-Price AS; Stephens JA; Zhang J; Backes FJ; Cohn DE; Suarez AA
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):438-45. PubMed ID: 26682991
[TBL] [Abstract][Full Text] [Related]
8. EXPRESSION LEVELS OF FOXO-1, P27KIP1, MIR-27, MIR-186 AND AKT1/AKT-P PROTEINS IN WOMEN WITH ENDOMETRIAL CANCER AND HYPERPLASIA: IMPLICATIONS FOR THE HUMAN REPRODUCTIVE SYSTEM.
Ghaderi P; Fallah S; Khaledi HR; Tehranian A; Rahmati F; Sheikhhasani S
Acta Endocrinol (Buchar); 2023; 19(1):1-9. PubMed ID: 37601705
[TBL] [Abstract][Full Text] [Related]
9. Clinical factors as prognostic variables among molecular subgroups of endometrial cancer.
Kolehmainen A; Pasanen A; Tuomi T; Koivisto-Korander R; Bützow R; Loukovaara M
PLoS One; 2020; 15(11):e0242733. PubMed ID: 33232359
[TBL] [Abstract][Full Text] [Related]
10. PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition.
Cretella D; Digiacomo G; Giovannetti E; Cavazzoni A
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31500143
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 and PTEN in human primary endometrial carcinomas: Clinicopathological and immunohistochemical analysis and study of their concomitant expression.
Stavropoulos A; Varras M; Vasilakaki T; Varra VK; Tsavari A; Varra FN; Nonni A; Kavantzas N; Lazaris AC
Oncol Lett; 2019 May; 17(5):4575-4589. PubMed ID: 30944646
[TBL] [Abstract][Full Text] [Related]
12. Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.
Nyasani E; Munir I; Perez M; Payne K; Khan S
Endocrine; 2019 Jan; 63(1):3-17. PubMed ID: 30218381
[TBL] [Abstract][Full Text] [Related]
13. Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.
Janouskova H; El Tekle G; Bellini E; Udeshi ND; Rinaldi A; Ulbricht A; Bernasocchi T; Civenni G; Losa M; Svinkina T; Bielski CM; Kryukov GV; Cascione L; Napoli S; Enchev RI; Mutch DG; Carney ME; Berchuck A; Winterhoff BJN; Broaddus RR; Schraml P; Moch H; Bertoni F; Catapano CV; Peter M; Carr SA; Garraway LA; Wild PJ; Theurillat JP
Nat Med; 2017 Sep; 23(9):1046-1054. PubMed ID: 28805821
[TBL] [Abstract][Full Text] [Related]
14. Features of endometrial cancer in patients with 'metabolically healthy' versus 'standard' obesity: the decreasing frequency of metabolically healthy obesity.
Berstein LM; Poroshina TE; Turkevich EA; Vasilyev DA; Baltrukova AN; Kovalenko IM; Berlev IV
Future Sci OA; 2015 Nov; 1(4):FSO68. PubMed ID: 28031919
[TBL] [Abstract][Full Text] [Related]
15. Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.
McCampbell AS; Mittelstadt ML; Dere R; Kim S; Zhou L; Djordjevic B; Soliman PT; Zhang Q; Wei C; Hursting SD; Lu KH; Broaddus RR; Walker CL
Curr Mol Med; 2016; 16(3):252-65. PubMed ID: 26917264
[TBL] [Abstract][Full Text] [Related]
16. Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis.
Secord AA; Hasselblad V; Von Gruenigen VE; Gehrig PA; Modesitt SC; Bae-Jump V; Havrilesky LJ
Gynecol Oncol; 2016 Jan; 140(1):184-90. PubMed ID: 26524722
[TBL] [Abstract][Full Text] [Related]
17. PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients.
Westin SN; Ju Z; Broaddus RR; Krakstad C; Li J; Pal N; Lu KH; Coleman RL; Hennessy BT; Klempner SJ; Werner HM; Salvesen HB; Cantley LC; Mills GB; Myers AP
Mol Oncol; 2015 Oct; 9(8):1694-703. PubMed ID: 26045339
[TBL] [Abstract][Full Text] [Related]
18. PTEN: Multiple Functions in Human Malignant Tumors.
Milella M; Falcone I; Conciatori F; Cesta Incani U; Del Curatolo A; Inzerilli N; Nuzzo CM; Vaccaro V; Vari S; Cognetti F; Ciuffreda L
Front Oncol; 2015; 5():24. PubMed ID: 25763354
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.
Berg A; Hoivik EA; Mjøs S; Holst F; Werner HM; Tangen IL; Taylor-Weiner A; Gibson WJ; Kusonmano K; Wik E; Trovik J; Halle MK; Øyan AM; Kalland KH; Cherniack AD; Beroukhim R; Stefansson I; Mills GB; Krakstad C; Salvesen HB
Oncotarget; 2015 Jan; 6(2):1327-39. PubMed ID: 25415225
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
